Jonathan Gorelick
Eastern Regional R&D Center
D, Israel
D, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Anti-Neuroinflammatory Cannabinoid Acids as a New Therapeutic Approach for Multiple Sclerosis.
Journal: Molecules (Basel, Switzerland)
Published: February 17, 2026
Natural Epithelial Barrier Integrity Enhancers-Citrus medica and Origanum dayi Extracts.
Journal: Gels (Basel, Switzerland)
Published: September 19, 2024
Selected cannabis cultivars modulate glial activation: in vitro and in vivo studies.
Journal: Journal of cannabis research
Published: June 06, 2023
Endocannabinoid basis of personality-Insights from animal model of social behavior.
Journal: Frontiers in pharmacology
Published: June 04, 2023
Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo.
Journal: Biomolecules
Published: December 25, 2022
Chiliadenus iphionoides Reduces Body Weight and Improves Parameters Related to Hepatic Lipid and Glucose Metabolism in a High-Fat-Diet-Induced Mice Model of NAFLD.
Journal: Nutrients
Published: September 23, 2022
Integration of the Connectivity Map and Pathway Analysis to Predict Plant Extract's Medicinal Properties-The Study Case of Sarcopoterium spinosum L.
Journal: Plants (Basel, Switzerland)
Published: July 20, 2022
Cannabis Extract Effects on Metabolic Parameters and Gut Microbiota Composition in a Mice Model of NAFLD and Obesity.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: April 08, 2022
THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet.
Journal: Journal of cannabis research
Published: July 04, 2021
Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat/Cholesterol Diet.
Journal: Cannabis and cannabinoid research
Published: September 14, 2020
Last Updated: 09/26/2026